A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 8,112 shares of TAK stock, worth $109,430. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,112
Previous 8,112 -0.0%
Holding current value
$109,430
Previous $104,000 10.58%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$13.89 - $15.04 $112,675 - $122,004
8,112 New
8,112 $113 Million
Q3 2023

Aug 14, 2024

BUY
$15.03 - $16.32 $151,322 - $164,309
10,068 Added 327.1%
13,146 $203 Million
Q2 2023

Aug 14, 2024

SELL
$15.57 - $17.11 $23,744 - $26,092
-1,525 Reduced 33.13%
3,078 $48.4 Million
Q1 2023

Aug 14, 2024

BUY
$15.28 - $16.48 $27,504 - $29,664
1,800 Added 64.22%
4,603 $75.9 Million
Q4 2022

Aug 14, 2024

SELL
$12.42 - $15.62 $1,366 - $1,718
-110 Reduced 3.78%
2,803 $43.7 Million
Q2 2022

Aug 14, 2024

SELL
$13.12 - $15.03 $1,705 - $1,953
-130 Reduced 4.27%
2,913 $40.9 Million
Q1 2022

Aug 14, 2024

SELL
$13.54 - $15.35 $68,634 - $77,809
-5,069 Reduced 62.49%
3,043 $43.6 Million
Q2 2021

Aug 30, 2024

SELL
$16.55 - $18.64 $85,712 - $96,536
-5,179 Reduced 63.84%
2,933 $49.4 Million
Q4 2020

Aug 30, 2024

BUY
$15.39 - $18.97 $9,234 - $11,382
600 Added 25.72%
2,933 $53.4 Million
Q1 2020

Aug 30, 2024

SELL
$13.02 - $20.31 $3,268 - $5,097
-251 Reduced 9.71%
2,333 $35.4 Million
Q4 2019

Aug 30, 2024

SELL
$16.88 - $20.83 $1,097 - $1,353
-65 Reduced 2.45%
2,584 $51 Million
Q1 2019

Aug 30, 2024

SELL
$16.7 - $21.52 $91,232 - $117,563
-5,463 Reduced 67.34%
2,649 $54 Million

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $41.9B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.